Back
Catalyst Pharmaceuticals 10K Form
Sell
46
CPRX
Catalyst Pharmaceuticals
Last Price:
21.04
Seasonality Move:
4.48%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive CPRX News And Ratings
See the #1 stock for the next 7 days that we like better than CPRX
CPRX Financial Statistics
Sales & Book Value
| Annual Sales: | $398.2M |
|---|---|
| Cash Flow: | $72.61M |
| Price / Cash Flow: | 11.43 |
| Annual Sales: | $5.54 |
| Price / Book: | 3.76 |
Profitability
| EPS (TTM): | 1.18000 |
|---|---|
| Net Income (TTM): | $142.8M |
| Gross Margin: | $346.24M |
| Return on Equity: | 27.81% |
| Return on Assets: | 23.73% |
Catalyst Pharmaceuticals Earnings Forecast
Key Catalyst Pharmaceuticals Financial Ratios
- The Gross Profit Margin over the past 22 years for CPRX is 86.95%.
- The Selling, General & Administrative Expenses for CPRX have been equal to 33.58% of Gross Profit Margin.
- The Research & Development expenses have been 23.39% of Revenue.
- The Interest Expense is 0.00% of Operating Income.
- Per Share Earnings over the last 22 years have been positive in 10 years.
Catalyst Pharmaceuticals Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | CPRX |
| CUSIP: | 14888U |
| Website: | catalystpharma.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 5.11 |
| Quick Ratio: | 4.75 |
Price-to-Earnings
| Trailing P/E Ratio: | 33.05 |
|---|---|
| Forward P/E Ratio: | 9.94 |
CPRX Technical Analysis vs Fundamental Analysis
Sell
46
Catalyst Pharmaceuticals (CPRX)
is a Sell
Is Catalyst Pharmaceuticals a Buy or a Sell?
-
Catalyst Pharmaceuticals stock is rated a Sell
The current Catalyst Pharmaceuticals [CPRX] share price is $21.15. The Score for CPRX is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.